Literature DB >> 9305351

Refined mapping of the epilepsy susceptibility locus EJM1 on chromosome 6.

T Sander1, B Bockenkamp, T Hildmann, R Blasczyk, R Kretz, T F Wienker, A Volz, B Schmitz, G Beck-Mannagetta, O Riess, J T Epplen, D Janz, A Ziegler.   

Abstract

Juvenile myoclonic epilepsy (JME) is a genetically determined common subtype of idiopathic generalized epilepsy. Linkage to the HLA complex on chromosome 6p21.3 and an allelic association with HLA-DR13 and -DQB1 alleles suggest that a susceptibility locus for JME, designated as "EJM1," is located within or near the HLA region. However, further studies revealed controversial results, and genetic heterogeneity has been suspected. The present study was designed to evaluate the validity of the association and linkage findings and to refine the map position of EJM1. Our association analysis showed no significant difference of the frequency of HLA-DR13 carriers in 62 German JME patients compared with that in 77 German controls (X2 = 0.98, df = 1, p = 0.161, one-tailed). Multipoint linkage analysis with use of microsatellite markers from the chromosomal region 6p25-q13 in 29 German families of JME patients provided significant evidence that an epilepsy locus (EJM1) close to the HLA locus confers susceptibility to "idiopathic" generalized seizures (Zmax = 3.27 at theta max = 0.033 centromeric to the HLA-DQ locus), assuming an autosomal dominant mode of inheritance with 70% penetrance. Haplotype analyses revealed key recombinations in five families, which locate EJM1 to the centromeric side of the HLA-DQ locus. This study confirms a causative role of EJM1 in the pathogenesis of idiopathic generalized seizures in the majority of German families of JME patients and refines a candidate region of 10.1 cM in the chromosomal region 6p21 between the flanking loci HLA-DQ and D6S1019. A possible explanation for the current controversial results in families of different populations might be ethnic variation of interfering polygenic effects that could be permissive for heterogeneous susceptibility alleles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305351     DOI: 10.1212/wnl.49.3.842

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Absence of GABRA1 Ala322Asp mutation in juvenile myoclonic epilepsy families from India.

Authors:  A Kapoor; J Vijai; H M Ravishankar; P Satishchandra; K Radhakrishnan; A Anand
Journal:  J Genet       Date:  2003 Apr-Aug       Impact factor: 1.166

2.  Susceptibility Gene for Juvenile Myoclonic Epilepsy Rings True.

Authors:  Robyn Wallace
Journal:  Epilepsy Curr       Date:  2004-01       Impact factor: 7.500

3.  A locus for juvenile myoclonic epilepsy maps to 2q33-q36.

Authors:  Rinki Ratnapriya; Joseph Vijai; Jayaram S Kadandale; Rajesh S Iyer; Kurupath Radhakrishnan; Anuranjan Anand
Journal:  Hum Genet       Date:  2010-05-14       Impact factor: 4.132

Review 4.  Genetic evaluation and counseling for epilepsy.

Authors:  Deb K Pal; Amanda W Pong; Wendy K Chung
Journal:  Nat Rev Neurol       Date:  2010-07-20       Impact factor: 42.937

Review 5.  The state of the art in the genetic analysis of the epilepsies.

Authors:  David A Greenberg; Deb K Pal
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

6.  Complex inheritance and parent-of-origin effect in juvenile myoclonic epilepsy.

Authors:  Deb K Pal; Martina Durner; Irene Klotz; Elisa Dicker; Shlomo Shinnar; Stanley Resor; Jeffrey Cohen; Cynthia Harden; Solomon L Moshé; Karen Ballaban-Gill; Edward B Bromfield; David A Greenberg
Journal:  Brain Dev       Date:  2006-01-18       Impact factor: 1.961

7.  BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy.

Authors:  Deb K Pal; Oleg V Evgrafov; Paula Tabares; Fengli Zhang; Martina Durner; David A Greenberg
Journal:  Am J Hum Genet       Date:  2003-06-25       Impact factor: 11.025

8.  Human gamma-aminobutyric acid type B receptors are differentially expressed and regulate inwardly rectifying K+ channels.

Authors:  K Kaupmann; V Schuler; J Mosbacher; S Bischoff; H Bittiger; J Heid; W Froestl; S Leonhard; T Pfaff; A Karschin; B Bettler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 9.  Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain.

Authors:  Danielle M Andrade
Journal:  Hum Genet       Date:  2009-06-18       Impact factor: 4.132

Review 10.  Evaluating candidate genes in common epilepsies and the nature of evidence.

Authors:  Deb K Pal; Lisa J Strug; David A Greenberg
Journal:  Epilepsia       Date:  2007-11-19       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.